MedPath
FDA Approval

Rivastigmine Transdermal System

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Bryant Ranch Prepack
DUNS: 171714327
Effective Date
August 30, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Rivastigmine(4.6 mg in 24 h)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Bryant Ranch Prepack

171714327

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bryant Ranch Prepack

Bryant Ranch Prepack

Bryant Ranch Prepack

171714327

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rivastigmine Transdermal System

Product Details

NDC Product Code
72162-1608
Application Number
ANDA209063
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
August 30, 2023
Code: PKI06M3IW0Class: ACTIBQuantity: 4.6 mg in 24 h
© Copyright 2025. All Rights Reserved by MedPath